Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares
(RTTNews) - Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.
Under the program, the Company may repurchase ordinary shares from time to time on the open market or through privately negotiated transactions or structured repurchase transactions.
As of June 30, 2022, the Company had cash and cash equivalents of $1.89 billion. The Company expects to fund the repurchase of its ordinary shares under the program with existing cash and cash equivalents.
read more
Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4
Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.
RTTNews
|
517 dni temu
Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD
Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.
RTTNews
|
772 dni temu
Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab
Biopharmaceutical company Xeris Biopharma Holdings, Inc. (XERS) announced Wednesday that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (HZNP).
RTTNews
|
799 dni temu
Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint
Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.
RTTNews
|
871 dni temu
European Shares Likely To Drift Lower On Tariff Worries
European stocks are seen opening broadly lower on Friday despite Apple posting a record revenue and Intel beating earnings and revenue expectations.
RTTNews
|
5g 38 minut temu
European Economic News Preview: German Inflation, Unemployment Data Due
Flash consumer prices, retail sales and unemployment figures from Germany and house prices from the UK are the top economic news due on Friday. At 2.00 am ET, the UK Nationwide house price data is due. Economists forecast house prices to grow 4.3 percent on a yearly basis in January following a 4.7 percent rise in December.
RTTNews
|
5g 50 minut temu
Sensex, Nifty Modestly Higher In Early Trade
Indian shares were modestly higher on Friday ahead of the Union Budget presentation this weekend and next week's MPC meeting.
RTTNews
|
6g 47 minut temu
Asian Markets Track Wall Street Higher
Asian stock markets are trading mostly higher on Friday, following the positive cues from Wall Street overnight, with markets in China, Hong Kong and Taiwan closed for Lunar New Year. The markets are also reacting positively to some domestic economic data from Japan and Australia. The markets are gaining from heavy buying in the tech space and firm metal prices that are pushing up mining stocks.
RTTNews
|
7g 53 minut temu
